News Releases News Releases Year None2020201920182016 Oct, 29 2020 TransMedics to Participate in Upcoming Virtual Investor Conferences Oct, 21 2020 TransMedics to Report Third Quarter 2020 Financial Results on November 4, 2020 Sep, 28 2020 TransMedics Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting Sep, 1 2020 TransMedics to Present at the 18th Annual Morgan Stanley Global Healthcare Conference Aug, 5 2020 TransMedics Reports Second Quarter 2020 Financial Results Jul, 28 2020 TransMedics to Present at the Canaccord 40th Annual Growth Conference Jul, 23 2020 TransMedics to Report Second Quarter 2020 Financial Results on August 5, 2020 May, 26 2020 TransMedics Announces Pricing of Public Offering of Common Stock May, 26 2020 TransMedics Announces Proposed Public Offering of Common Stock May, 26 2020 TransMedics Announces Positive Top-line Results from U.S. Pivotal OCS™ Liver PROTECT Trial Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 17
News Releases Year None2020201920182016 Oct, 29 2020 TransMedics to Participate in Upcoming Virtual Investor Conferences Oct, 21 2020 TransMedics to Report Third Quarter 2020 Financial Results on November 4, 2020 Sep, 28 2020 TransMedics Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting Sep, 1 2020 TransMedics to Present at the 18th Annual Morgan Stanley Global Healthcare Conference Aug, 5 2020 TransMedics Reports Second Quarter 2020 Financial Results Jul, 28 2020 TransMedics to Present at the Canaccord 40th Annual Growth Conference Jul, 23 2020 TransMedics to Report Second Quarter 2020 Financial Results on August 5, 2020 May, 26 2020 TransMedics Announces Pricing of Public Offering of Common Stock May, 26 2020 TransMedics Announces Proposed Public Offering of Common Stock May, 26 2020 TransMedics Announces Positive Top-line Results from U.S. Pivotal OCS™ Liver PROTECT Trial Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 17
Sep, 28 2020 TransMedics Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting
May, 26 2020 TransMedics Announces Positive Top-line Results from U.S. Pivotal OCS™ Liver PROTECT Trial
